Thus far, the value of 68Ga-PSMA PET in the accurate detection and delineation of intraprostatic tumor burden, which is important for diagnosis and treatment planning for patients with primary prostate cancer, is poorly explored. This evidence concerns the gene FOLH1 and prostate cancer.